Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Medtronic to $77 from $82 and keeps an Equal Weight rating on the shares. The analyst is updating his 2024 and forward EPS forecast for Medtronic, as he corrects for the company’s expected FX impact on EPS.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MDT: